The global cell therapy manufacturing market, valued at USD 6.3 billion in 2025, is projected to reach USD 7.2 billion in 2026 and USD 14.0 billion by 2035, representing a CAGR of 7.7% during the forecast period 2026 to 2035. Researchers are investigating more than 1,000 cell and gene therapy candidates for the treatment of a myriad of disease indications. Amongst these, around 45 cell-based therapies have already been approved by various regulatory authorities across the globe. Further, several...

The global CAR-T cell therapy market, valued at USD 6.1 billion in 2025, is projected to reach USD 7.7 billion in 2026 and USD 15.6 billion by 2035, with a 8.1% CAGR during the forecast period 2026 to 2035. In terms of target antigen, the CD19 targeting therapies segment holds the highest share (more than 65%) of the market. With regards to target indication, the multiple myeloma segment dominates the global market with close to 30% market share. In terms of geographical regions, North America c...

The stem cell therapy market, valued at USD 204 million in 2025, is projected to reach USD 321 million in 2026 and USD 1,290 million by 2035, representing a CAGR of 16.7% during the forecast period 2026 to 2035. Based on end users, hospitals dominate the overall market as they possess the specialized infrastructure and expertise required to administer advanced stem cell therapies. Across key geographical regions, North America captures the largest market share owing to substantial research fundi...

With accelerated approval from the USFDA, several industrial players are taking strategic initiatives for technological innovations that help to explore more applications autologous cell therapies beyond cancer and autoimmune diseases. For instance, in November 2024, Nature Cell (a Korean biotechnology company) announced the success of autologous adipose stem cells that are delivered into spinal cavity of patient to treat Parkinson’s disease. This therapy has been developed by Japan Angel Stem...

The global allogeneic cell therapy market valued at USD 50.0 million in 2025, is projected to grow to USD 52.4 million in 2026 and USD 1,629.6 million by 2035, representing a CAGR of 46.5% during the forecast period 2026 to 2035. Over the past few years, a number of allogeneic cell therapies targeting a myriad of disorders, such as hematological malignancies and neurological disorders have received approval from various regulatory authorities, globally. In December 2022, the European Commission...

The global cell therapy packaging market, valued at USD 404 million in 2025, is projected to reach USD 456 million in 2026 and USD 1,225 million by 2035, with a 11.6% CAGR during the forecast period 2026 to 2035. According to our projections, Asia-Pacific captures the major share (41%) in cell therapy packaging market and this trend is unlikely to change in the future. It is further worth highlighting that the cell therapy packaging in Europe is expected to grow at a relatively healthy CAGR (...

The global T-cell therapy market, valued at USD 6.5 billion in 2025, is projected to grow to USD 8.1 billion in 2026 and USD 20.9 billion by 2035, representing a CAGR of 11.2% during the forecast period 2026 to 2035. According to NIH, in 2024, around 2 million people are estimated to be diagnosed with various types of cancer in the U.S. alone. The US FDA approved multiple T cell therapies targeting cancer (in reverse chronological order), such as Obecabtagene autoleucel / Aucatzyl (relapsed or r...

The global cell therapy media market, valued at USD 1.6 billion in 2025, is projected to reach USD 1.8 billion in 2026 and USD 4.5 billion by 2035, with a 10.6% CAGR during the forecast period 2026 to 2035. The cell therapy consumable providers market landscape features more than 80 companies, which claim to possess the necessary expertise for manufacturing of over 450 research and / or therapeutic grade raw materials. Further, it is worth highlighting that more than USD 35 billion has already i...

The global plasmid DNA manufacturing market, valued at USD 317 million in 2025, is projected to reach USD 395 million in 2026 and USD 2,689 million by 2035, representing a CAGR of 23.74% during the forecast period 2026 to 2035. The success of plasmid-based platforms during the COVID-19 pandemic (used by companies like Moderna and Pfizer-BioNTech) highlighted their importance in rapid vaccine development. This has driven sustained demand for plasmid DNA in DNA / RNA vaccines, infectious disease r...

The global veterinary regenerative medicine market size, valued at USD 388 Million in 2025, is projected to reach USD 437 Million in 2026 and USD 1,189 Million by 2035, representing a CAGR of 11.8% during the forecast period. In terms of product, stem cell therapies is securing 53% of the market share driven by the widespread adoption of these therapies to treat wounds, damages tissues and chronic conditions. With regards to end user, the veterinary hospitals / clinics segment holds the highest...

The global cell and gene therapy supply chain software market, valued at USD 312 million in 2025, is projected to reach USD 356 million in 2026 and USD 1,329 million by 2035, representing a CAGR of 15.8% during the forecast period 2026 to 2035. According to a report published by Novotech, it was anticipated that more than 12 novel cell and gene therapies would be approved by the end of 2023, highlighting lucrative opportunities for stakeholders in this market. Moreover, post-2018, over 40% of th...

The global gene switch market, valued at USD 795 million in 2025, is projected to reach USD 899 million in 2026 and USD 2,478 billion by 2035, with a 11.93% CAGR during the forecast period 2026 to 2035. Notably, in the past few years, close to 30 cell and gene therapy products have been approved by the US FDA. In addition, over 1,200 cell therapies are currently being evaluated across various clinical stages of development. However, despite various advantages, adverse events are associated with...

The global cell and gene therapy manufacturing market size, valued at USD 11.9 billion in 2024, is projected to reach USD 15.1 billion in 2025 and USD 160.0 billion by 2035, representing a CAGR of 26.64% during the forecast period. According to our projection, North America has the highest share (45%) of the market and the trend of dominance is likely to remain unchanged during the forecast period. North American region is currently dominating the industry with the highest share of 45%. . Accord...

The global amyotrophic lateral sclerosis market size is valued at USD 0.79 billion in 2024 and is estimated to reach USD 1.38 billion by 2035, representing a CAGR of 5.2% during the forecast period. It is important to highlight here that in May 2024, European Medicines Agency (EMA) approved Biogen

The global cell and gene therapy CRO market, valued at USD 1.7 billion in 2024, is estimated to reach USD 1.9 billion in 2025 and USD 3.5 billion by 2035, representing a CAGR of 6.3% during the forecast period. Presently, over 90 cell and gene therapies have been approved globally. Notable examples of recently approved therapies include (in reverse chronological order of year of approval) Fucaso (2023; developed by IASO Bio) for the treatment of multiple myeloma, Elvediys, (2023; developed by Sa...

The novel T-cell immunotherapy market is estimated to be worth $25 million in 2021 and is expected to grow at CAGR of 76% during the forecast period. At present, the novel T-cell immunotherapies pipeline features over 200 product candidates and is anticipated to grow in the foreseen future. Further, more than 35 such therapies, including Tab-cel

The global biologics contract research organization market size, valued at USD 27.0 billion in 2024, is projected to reach USD 36.0 billion in 2025 and USD 126.0 billion by 2035, representing a CAGR of 13% during the forecast period. According to the biologics contract research organization market report, presently the antibodies segment holds the highest share (45%), and the trend is likely to remain unchanged. Among these, the clinical segment holds the largest biologics contract research orga...